De novo variants were identified in three known PAH risk genes (four variants in TBX4, two in BMPR2, one in ACVRL1) and 23 additional genes with high expression in developing lung and/or heart but little to no previous association with PAH. Here, TBX4 is linked to pulmonary arterial hypertension.